Network pharmacological analyses indicated that IL-6 ranked second in the PPI network and exhibited the highest binding affinity with hesperetin, positioning it as a pivotal node linking inflammation (KEGG: JAK-STAT signaling) and metabolic dysfunction (NAFLD pathway). The gene discussed is IL6; the disease is metabolic dysfunction-associated steatotic liver disease.